This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fundacio Privada Parc Cientific De Barcelona, Institucio Catalana De Recerca I Estudis Avancats. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 93 
Years Active: 2012
Title: Inventor Manuel Castro De Moura: Pioneering Aminoacyl-tRNA Synthetase Inhibitors
Introduction: Manuel Castro De Moura, based in Lloret de Mar, Spain, is an innovative inventor known for his contributions to the field of biochemistry. He holds one patent that represents a significant advancement in the identification of inhibitors for aminoacyl-tRNA synthetases, which are vital in protein synthesis.
Latest Patents: De Moura's patent, titled "Screening method for identifying new aminoacyl-tRNA synthetase inhibitors," outlines a comprehensive method for discovering new drug candidates. The patent describes a process that includes obtaining and engineering gene sequences for naturally occurring aminoacyl-tRNA synthetases, transforming mammalian cells, and analyzing the effects of test substances on cell growth. The patented method is noteworthy for its potential to identify substances that selectively inhibit engineered synthetases, offering crucial insights into possible therapeutic applications.
Career Highlights: De Moura has worked with reputable institutions, including the Fundació Privada Parc Científic de Barcelona and the Institució Catalana de Recerca i Estudis Avançats. His expertise and creativity have allowed him to contribute to groundbreaking research and development in the field of enzymology and synthetic biology.
Collaborations: Throughout his career, De Moura has collaborated with notable figures in the scientific community, such as Lluis Ribas De Pouplana and Teresa Bori Sanz. These collaborations have fostered innovative research projects and have expanded the understanding of aminoacyl-tRNA synthetases.
Conclusion: Manuel Castro De Moura exemplifies the spirit of innovation in the scientific domain. His patented method for identifying aminoacyl-tRNA synthetase inhibitors not only demonstrates his ingenuity but also highlights the importance of interdisciplinary collaboration in advancing research. As he continues to contribute to the field, his work may pave the way for new therapeutic strategies in medication development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile